Those administering COVID vaccine should be trained in use of EpiPen | Opinion
Updated Dec 17, 2020;
Posted Dec 17, 2020
Valerie Bolcar, a registered nurse at the Morristown, N.J., Medical Center, prepares to administer the COVID-19 vaccine to frontline workers on Tuesday.
Patti Sapone | NJ Advance Media
Facebook Share
By Robert K. Houton
The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine.
Those who give the COVID-19 vaccine need to be trained to use an EpiPen | Opinion
Updated Dec 15, 2020;
Posted Dec 15, 2020
About 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine. Robert K. Houton, founder of the Training Epinephrine Administrators in Medication (TEAM) Association, is working with the FDA to get those who administer the vaccine training in using EpiPens.(AP Photo/Mark Lennihan, Pool)AP
Facebook Share
By Robert K. Houton
The COVID-19 vaccination that began rolling out this week to frontline medical workers will hopefully end our long nightmare with this virus and the pandemic. But there is one concern: 1.6% of the American population, or roughly 5 million people, have experienced a severe allergic attack, called anaphylaxis, and may have a severe reaction to the vaccine.